27384243|t|Conditional ablation of myeloid TNF increases lesion volume after experimental stroke in mice, possibly via altered ERK1/2 signaling
27384243|a|Microglia are activated following cerebral ischemia and increase their production of the neuro - and immunomodulatory cytokine tumor necrosis factor (TNF). To address the function of TNF from this cellular source in focal cerebral ischemia we used TNF conditional knock out mice (LysMcreTNF(fl/fl)) in which the TNF gene was deleted in cells of the myeloid lineage, including microglia. The deletion reduced secreted TNF levels in lipopolysaccharide -stimulated cultured primary microglia by ~93%. Furthermore, phosphorylated-ERK / ERK ratios were significantly decreased in naïve LysMcreTNF(fl/fl) mice demonstrating altered ERK signal transduction. Micro-PET using (18)[F]-fluorodeoxyglucose immediately after focal cerebral ischemia showed increased glucose uptake in LysMcreTNF(fl/fl) mice, representing significant metabolic changes, that translated into increased infarct volumes at 24 hours and 5 days compared to littermates (TNFfl/fl). In naïve LysMcreTNF(fl/fl) mice cytokine levels were low and comparable to littermates. At 6 hours, TNF producing microglia were reduced by 56% in the ischemic cortex in LysMcreTNF(fl/fl) mice compared to littermate mice, whereas no TNF(+) leukocytes were detected. At 24 hours, pro-inflammatory cytokine (TNF, IL-1β, IL-6, IL-5 and CXCL1) levels were significantly lower in LysMcreTNF(fl/fl) mice, despite comparable infiltrating leukocyte populations. Our results identify microglia l TNF as beneficial and neuroprotective in the acute phase and as a modulator of neuroinflammation at later time points after experimental ischemia, which may contribute to regenerative recovery.
27384243	12	20	ablation	T061	C0547070
27384243	24	31	myeloid	T080	C0439677
27384243	32	35	TNF	T116,T129	C0041368
27384243	46	52	lesion	T033	C0221198
27384243	53	59	volume	T081	C0449468
27384243	66	93	experimental stroke in mice	T050	C0012644
27384243	116	132	ERK1/2 signaling	T044	C2611831
27384243	133	142	Microglia	T025	C0206116
27384243	167	184	cerebral ischemia	T047	C0917798
27384243	222	227	neuro	T123	C0949370
27384243	234	250	immunomodulatory	T121,T129	C0005525
27384243	251	259	cytokine	T116,T129	C0079189
27384243	260	281	tumor necrosis factor	T116,T129	C0041368
27384243	283	286	TNF	T116,T129	C0041368
27384243	304	312	function	T169	C0542341
27384243	316	319	TNF	T116,T129	C0041368
27384243	330	345	cellular source	T033	C0449416
27384243	349	372	focal cerebral ischemia	T047	C0917798
27384243	381	384	TNF	T116,T129	C0041368
27384243	397	431	knock out mice (LysMcreTNF(fl/fl))	T015	C0206745
27384243	445	453	TNF gene	T028	C0812246
27384243	458	465	deleted	T052	C1880274
27384243	469	474	cells	T025	C0007634
27384243	482	497	myeloid lineage	T078	C0282637
27384243	509	518	microglia	T025	C0206116
27384243	524	532	deletion	T045	C0017260
27384243	550	553	TNF	T116,T129	C0041368
27384243	554	560	levels	T080	C0441889
27384243	564	582	lipopolysaccharide	T109	C0023810
27384243	595	621	cultured primary microglia	T025	C0007635
27384243	644	662	phosphorylated-ERK	T116,T126	C0752312
27384243	665	668	ERK	T116,T126	C0752312
27384243	669	675	ratios	T081	C0456603
27384243	708	736	naïve LysMcreTNF(fl/fl) mice	T015	C0026809
27384243	759	762	ERK	T116,T126	C0752312
27384243	763	782	signal transduction	T043	C0037083
27384243	784	793	Micro-PET	T060	C0032743
27384243	800	826	(18)[F]-fluorodeoxyglucose	T109,T130	C0046056
27384243	845	868	focal cerebral ischemia	T047	C0917798
27384243	886	900	glucose uptake	T043	C1159527
27384243	904	926	LysMcreTNF(fl/fl) mice	T015	C0026809
27384243	953	962	metabolic	T040	C0025519
27384243	963	970	changes	T169	C0392747
27384243	1003	1010	infarct	T046	C0021308
27384243	1011	1018	volumes	T081	C0449468
27384243	1037	1041	days	T079	C0439228
27384243	1054	1076	littermates (TNFfl/fl)	T015	C0026809
27384243	1081	1109	naïve LysMcreTNF(fl/fl) mice	T015	C0026809
27384243	1110	1118	cytokine	T116,T129	C0079189
27384243	1119	1125	levels	T080	C0441889
27384243	1153	1164	littermates	T015	C0026809
27384243	1178	1181	TNF	T116,T129	C0041368
27384243	1192	1201	microglia	T025	C0206116
27384243	1229	1244	ischemic cortex	T046	C0022116
27384243	1248	1270	LysMcreTNF(fl/fl) mice	T015	C0026809
27384243	1283	1298	littermate mice	T015	C0026809
27384243	1311	1317	TNF(+)	T028	C0812246
27384243	1318	1328	leukocytes	T025	C0023516
27384243	1357	1382	pro-inflammatory cytokine	T116,T129	C0079189
27384243	1384	1387	TNF	T116,T129	C0041368
27384243	1389	1394	IL-1β	T116,T129	C0021753
27384243	1396	1400	IL-6	T116,T129	C0021760
27384243	1402	1406	IL-5	T116,T129	C0021759
27384243	1411	1416	CXCL1	T116,T123	C0635817
27384243	1418	1424	levels	T080	C0441889
27384243	1453	1475	LysMcreTNF(fl/fl) mice	T015	C0026809
27384243	1509	1530	leukocyte populations	T025	C0023516
27384243	1553	1562	microglia	T025	C0206116
27384243	1565	1568	TNF	T116,T129	C0041368
27384243	1587	1602	neuroprotective	T169	C0815279
27384243	1610	1621	acute phase	T079	C0439557
27384243	1644	1661	neuroinflammation	T046	C0021368
27384243	1702	1710	ischemia	T046	C0022116
27384243	1736	1757	regenerative recovery	T040	C2004454